A PP4 Holoenzyme Balances Physiological and Oncogenic Nuclear Factor-Kappa B Signaling in T Lymphocytes-Reference-Cited by-同舟云学术

A PP4 Holoenzyme Balances Physiological and Oncogenic Nuclear Factor-Kappa B Signaling in T Lymphocytes

Published:2012-10 Issue:4 Volume:37 Page:697-708
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Brechmann Markus,Mock Thomas,Nickles Dorothee,Kiessling Michael,Weit Nicole,Breuer Rebecca,Müller Wolfgang,Wabnitz Guido,Frey Felice,Nicolay Jan P.,Booken Nina,Samstag Yvonne,Klemke Claus-Detlev,Herling Marco,Boutros Michael,Krammer Peter H.,Arnold Rüdiger

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference41 articles.

1. Tailoring T-cell receptor signals by proximal negative feedback mechanisms;Acuto;Nat. Rev. Immunol.,2008

2. Caspase-mediated cleavage of hematopoietic progenitor kinase 1 (HPK1) converts an activator of NFkappaB into an inhibitor of NFkappaB;Arnold;J. Biol. Chem.,2001

3. The two NF-kappaB activation pathways and their role in innate and adaptive immunity;Bonizzi;Trends Immunol.,2004

4. Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death;Brenner;EMBO J.,2005

5. PPX, a novel protein serine/threonine phosphatase localized to centrosomes;Brewis;EMBO J.,1993

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional CRISPR screens in T cells reveal new opportunities for cancer immunotherapies;Molecular Cancer;2024-04-05

2. PP4R1 Induced Cancer Stemness by Upregulating the Expression of OCT4 via the MAPK/ERK Pathway in NSCLC;J BIOL REG HOMEOS AG;2024

3. AMBRA1 promotes intestinal inflammation by antagonizing PP4R1/PP4c mediated IKK dephosphorylation in an autophagy-independent manner;Cell Death & Differentiation;2024-02-29

4. PP4R1 accelerates the malignant progression of NSCLC via up-regulating HSPA6 expression and HSPA6-mediated ER stress;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-01

5. DOK3 promotes atopic dermatitis by enabling the phosphatase PP4C to inhibit the T cell signaling mediator CARD11;Science Signaling;2023-10-31